Facebook Pixel
Prognosis: Losing it

Johnson & Johnson's CEO on the Newest Vaccine

Prognosis: Losing it
Prognosis: Losing it

Now that Johnson & Johnson’s Covid-19 vaccine has been cleared by regulators, the company needs to ramp up doses fast. J and J is looking for manufacturing partnerships to increase supply. Riley Griffin spoke to the company’s chief executive officer, Alex Gorsky about his plan to immunize 20 million Americans by the end of the month, and 100 million by the end of June.

See omnystudio.com/listener for privacy information.

Prognosis: Losing it
Not playing